24 May 2013
Keywords: celltech, pde, iv, inhibitor, asthma, shows, promise
Article | 18 December 1995
Celltech of the UK has announced progress with several of its product
development programs, including its phosphodiesterase IV inhibitor for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 December 1995
23 May 2013
© 2013 thepharmaletter.com